Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes

• Váldodahkkit: Valentina Guarnotta (Dahkki), Gianluca Cuva (Dahkki), Maria Pia Imbergamo (Dahkki), Carla Giordano (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset during pregnancy. It is characterized by high risk of adverse outcomes for the mother and the foetus, if not adequately controlled. The aim of the study was to evaluate the effects of 4000 mg of myoi...